Skip to main content
Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · IEX Real-Time Price · USD
0.930
-0.020 (-2.14%)
At close: May 3, 2024, 4:00 PM
0.975
+0.045 (4.87%)
After-hours: May 3, 2024, 7:52 PM EDT

Lucid Diagnostics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202320222021
Market Capitalization
466353198
Market Cap Growth
-18.41%-73.09%-
Enterprise Value
435933144
PE Ratio
-1.20-1.20-0.95-7.04
PS Ratio
19.0625.94141.08395.33
PB Ratio
-27.25-27.252.313.61
P/FCF Ratio
-1.91-1.91-1.74-10.67
P/OCF Ratio
-1.92-1.92-1.79-11.19
EV/Sales Ratio
17.5624.4486.77288.01
EV/EBITDA Ratio
-1.19-1.19-0.60-5.25
EV/EBIT Ratio
-1.14-1.14-0.58-5.25
EV/FCF Ratio
-1.80-1.80-1.07-7.77
Debt / Equity Ratio
-6.60-6.600.09-
Debt / EBITDA Ratio
-0.31-0.31-0.04-
Debt / FCF Ratio
-0.46-0.46-0.07-
Quick Ratio
0.640.642.6712.64
Current Ratio
0.750.752.8913.45
Asset Turnover
0.060.060.010.02
Interest Coverage
-125.60-125.60-7020.37-41.61
Return on Equity (ROE)
-523.80%-523.80%-168.50%-136.20%
Return on Assets (ROA)
-138.50%-138.50%-126.00%-91.80%
Return on Capital (ROIC)
-374.55%-374.55%-224.59%-50.09%
Earnings Yield
-113.79%-83.62%-105.61%-14.21%
FCF Yield
-71.38%-52.46%-57.52%-9.37%
Buyback Yield / Dilution
-15.44%-15.44%-94.44%-31.81%
Total Shareholder Return
-15.44%-15.44%-94.44%-31.81%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).